Atrial Fibrillation Therapies

The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding. 

A study led by researchers at the University of North Carolina indicates a newly approved blood thinner blocks a key component of the human blood clotting system and may increase the risk and severity of certain viral infections, including flu and...

Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co-primary endpoints. The data was supposed to be presented during the 2013 American College of Cardiology (ACC) meeting on March 9 as the lead-off late...

New research presented at Heart Rhythm 2013 continues to show promising results for focal impulse and rotor modulation (FIRM) mapping to effectively target...
Endosense, tacticath, contact force, electrophysiology
New study data released at the Heart Rhythm Society (HRS) meeting last week validates the importance of contact force technology focused on improving the...
nContact Inc. said it received conditional approval for an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to...
Thermocool Smarttouch, Biosense webster force sensing
Biosense Webster Inc. announced the 12-month safety and effectiveness results of the Thermocool Smarttouch catheter and software module in the treatment of...
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K
The Biotronik Lumax 740 DX system is a first-in-class implantable cardiac defibrillator (ICD) that utilizes a single lead...
The VisiTrax cardiac ablation device, EPi-Sense, now has embedded sensing capability. This next generation of technology includes sensors...

Articles

New research presented at Heart Rhythm 2013 continues to show promising results for focal impulse and rotor modulation (FIRM) mapping to effectively target...
nContact Inc. said it received conditional approval for an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to...
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K antagonist (VKA)...

Video Center

Over the past decade in the United States, there has been growing interest in transradial artery...
10 weeks 4 days ago
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
14 weeks 6 days ago
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
18 weeks 4 days ago
EP lab, Tom De potter, depotter, angiography dose reduction
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available